We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Device for Injecting Stem Cells into the Heart

By HospiMedica staff writers
Posted on 26 Jun 2003
A new device is designed to deliver a patient's own adult stem cells through the coronary arteries to the heart to treat damage to the heart.

Called MicroSyringe, the device contains a C-shaped balloon that when inflated pushes a microscopic needle into the wall of the coronary arteries and injects the stem cells into the perivascular tissue. More...
Studies have shown that autologous bone marrow stem cells injected into the heart can help to cure heart damage, improving blood flow and shrinking scars.

There may be a proportional response between the number of cells delivered and the amount of healing observed, according to the developer of the syringe, suggesting that more stem cells would promote more healing. The direct-injection method prevents the bloodstream from washing away the cells. The MicroSyringe was developed by EndoBionics, Inc. (San Leandro, CA, USA).

"Delivering the cells just outside the artery with the MicroSyringe deposits them in an oxygen- and blood-rich area that is critical to cell survival,” said Robert Cafferata, Ph.D., executive vice president of Endobionics.




Related Links:
EndoBionics

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.